Business Description
Tenaya Therapeutics is a US-based company focused on finding new treatments for heart disease, currently running several clinical trials. Its pipeline includes two gene therapies targeting inherited heart conditions and a small molecule drug for a form of heart failure that has limited treatment options today. The company draws on a range of scientific approaches, including gene addition, editing, and silencing, and works with Alnylam Pharmaceuticals to identify new targets in cardiovascular disease. Founded in 2016 and based in South San Francisco, Tenaya is working to build a broad platform for addressing serious cardiac conditions.
